Search
Descriptor English: Androstenediol
Descriptor Spanish: Androstenodiol
Descriptor androstenodiol
Scope note: Intermediario en la biosíntesis de la TESTOSTERONA que se encuentra el TESTÍCULO o las GLÁNDULAS SUPRARRENALES. El androstenodiol, derivado de la DESHIDROEPIANDROSTERONA por reducción del grupo 17-ceto (17-HIDROXIESTEROIDE DESHIDROGENASAS), se convierte en TESTOSTERONA por oxidación del grupo 3-beta hidroxilo que da lugar a un grupo 3-ceto (3-HIDROXIESTEROIDE DESHIDROGENASAS).
Descriptor Portuguese: Androstenodiol
Descriptor French: Androstènediol
Entry term(s): 5 Androstene 3,17 diol
5 Androstene 3beta 17beta Diol
5-Androstene-3,17-diol
5-Androstene-3beta-17beta-Diol
Androst 5 ene 3 beta,17 beta Diol
Androst 5 ene 3,17 diol
Androst-5-ene-3 beta,17 beta-Diol
Androst-5-ene-3,17-diol
Bisexovister
Delta 5 Androstenediol
Delta 5-Androstenediol
Hermaphrodiol
delta 5 Androstene 3 beta,17 beta Diol
delta 5-Androstene-3 beta,17 beta-Diol
Tree number(s): D04.210.500.054.079.429.154.050
D06.472.334.851.968.750
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D015114
Scope note: An intermediate in TESTOSTERONE biosynthesis, found in the TESTIS or the ADRENAL GLANDS. Androstenediol, derived from DEHYDROEPIANDROSTERONE by the reduction of the 17-keto group (17-HYDROXYSTEROID DEHYDROGENASES), is converted to TESTOSTERONE by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-HYDROXYSTEROID DEHYDROGENASES).
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anabolic Agents
Registry Number: 95PS51EMXY
CAS Type 1 Name: Androst-5-ene-3,17-diol, (3beta,17beta)-
Previous Indexing: Androstenediols (1975)
Public MeSH Note: 2004; see ANDROST-5-ENE-3 BETA,17 BETA-DIOL 1998-2003, see 5-ANDROSTENE-3,17-DIOL 1991-1997, see ANDROSTENEDIOLS 1976-1990
History Note: 2004 (1976); use 5-ANDROSTENE-3,17-DIOL 1991-1997, use ANDROSTENEDIOLS 1976-1990
DeCS ID: 747
Unique ID: D015114
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1991/01/01
Date of Entry: 1975/07/18
Revision Date: 2017/05/24
Androstenediol - Preferred
Concept UI M0023251
Scope note An intermediate in TESTOSTERONE biosynthesis, found in the TESTIS or the ADRENAL GLANDS. Androstenediol, derived from DEHYDROEPIANDROSTERONE by the reduction of the 17-keto group (17-HYDROXYSTEROID DEHYDROGENASES), is converted to TESTOSTERONE by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-HYDROXYSTEROID DEHYDROGENASES).
Preferred term Androstenediol
Entry term(s) 5 Androstene 3,17 diol
5 Androstene 3beta 17beta Diol
5-Androstene-3,17-diol
5-Androstene-3beta-17beta-Diol
Androst 5 ene 3 beta,17 beta Diol
Androst 5 ene 3,17 diol
Androst-5-ene-3 beta,17 beta-Diol
Androst-5-ene-3,17-diol
Delta 5 Androstenediol
Delta 5-Androstenediol
Hermaphrodiol
delta 5 Androstene 3 beta,17 beta Diol
delta 5-Androstene-3 beta,17 beta-Diol
Bisexovister - Narrower
Concept UI M0433954
Preferred term Bisexovister



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey